2026 September - 7 articles
Pulmonary diseases, including tuberculosis (TB), chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and pulmonary fibrosis, remain a leading cause of morbidity and mortality worldwide, and each presents a different combination of diag...
Immunotherapy can reduce treatment-related side effects but shows limited efficacy in “cold tumors,” whose immunosuppressive tumor immune microenvironment is characterized by abundant M2 macrophages and poor T cell infiltration. Because b...
Hydrogel-forming microneedles (HFMNs) are minimally invasive interfaces that access interstitial fluid (ISF) through skin penetration, swelling-mediated uptake, analyte diffusion, and hydrated sensor integration. This review examines HFMN architectur...
Theranostic nanoparticles, which integrate diagnostic imaging and therapeutic delivery within a single nanoplatform, represent a transformative paradigm in oncological nanomedicine. Despite substantial preclinical progress, the field faces persistent...
Cancer diagnosis and longitudinal monitoring increasingly depend on biosensing technologies capable of detecting low-abundance, heterogeneous, and dynamic biomarkers in complex biological samples. Hydrogel-based biosensors offer a distinctive materia...
Asthma is a prevalent, long-term inflammatory airway condition that is difficult to diagnose and treat because there is no single reliable diagnostic test. Misdiagnosis is therefore common, with rates as high as 73% in juvenile groups and up to 35% i...
Theranostics is a novel approach that integrates diagnostic and therapeutic efficacy on a single platform, holding great promise for precision medicine by enabling real-time monitoring of disease progression and therapeutic response. Despite signific...
